“TCM/MdBio is an outstanding organization that I have been associated with for two years. Many companies grow and benefit from their services, education and awareness. I hope to give back to this organization, in this role of Chairman, as much as it has given to my companies and me,” remarked Mr. Trevisan.
Mr. Trevisan understands the needs and aspirations of companies large and small in this industry and brings a diverse background to TCM/MdBio in the role of Chairman. He is no stranger to local biotech endeavors in Maryland, having started several successful drug development research organizations. Most recently, Accelovance was formed in 2004, servicing the clinical needs of biotech, pharma and contract research organization (CRO) clients by offering research-dedicated clinical sites, flexible CRO services and patient recruitment. The company has grown in the US and has expanded to China, capitalizing on the country’s emergence as an emerging market for research and drug development.
In 2006, the independent organizations of Technology Council of Maryland (TCM) and MdBio merged. The union of these two groups leveraged the strengths of having bioscience and advanced technology together to collectively serve the areas of common interest for Maryland’s technology based companies.
Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique system for delivering quality, on time, and cost effective clinical studies. Accelovance offers CRO services, clinical sites and a dedicated patient recruitment department with call center. In China, the Company operates through its wholly-owned foreign enterprise in Beijing as a (CRO). Accelovance is focused on optimizing the quality and productivity of multiple clinical sites, through strong central management and targeted pro-active patient recruitment. Delivering high quality and timely clinical trial support services, Accelovance is committed to understanding and meeting its clients needs to contribute to their success.
For more information, visit the company’s website at http://www.accelovance.com.
CONTACT: Media: Garrett D. Smith at 240.238.4900
